Literature DB >> 23401296

Lewy body pathology in a patient with a homozygous parkin deletion.

Saori Miyakawa1, Mieko Ogino, Sayaka Funabe, Akiko Uchino, Yasushi Shimo, Nobutaka Hattori, Masaaki Ichinoe, Tetuo Mikami, Makoto Saegusa, Kazutoshi Nishiyama, Hideo Mori, Yoshikuni Mizuno, Shigeo Murayama, Hideki Mochizuki.   

Abstract

BACKGROUND: We report neuropathologic findings in a patient with homozygous deletions of exons 2 to 4 of parkin.
RESULTS: Although the absence of Lewy bodies has been considered a neuropathologic characteristic of parkin mutation, here we report a pathologic finding with the presence of Lewy bodies.
METHODS: The patient was a 72-year-old woman with onset of the disease at age 61. Her autopsy revealed marked decrease in melanized neurons in the substantia nigra and the locus coeruleus. Lewy bodies were found in the substantia nigra, the locus coeruleus, the dorsal motor nucleus of the vagus, the basal nucleus of Meynert, the amygdaloid nucleus, and the sympathetic nerve bundles in the myocardium.
CONCLUSIONS: Only 3 previous case reports described Lewy body formation in patients carrying parkin mutations. The distribution of Lewy bodies in our patient appeared to be reminiscent of sporadic Parkinson's disease.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23401296     DOI: 10.1002/mds.25346

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

1.  Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.

Authors:  Anna De Rosa; Teresa Pellegrino; Sabina Pappatà; Maria Teresa Pellecchia; Silvio Peluso; Francesco Saccà; Paolo Barone; Alberto Cuocolo; Giuseppe De Michele
Journal:  J Nucl Cardiol       Date:  2015-12-01       Impact factor: 5.952

2.  A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Authors:  Mario R Cornejo-Olivas; Luis Torres; Ignacio F Mata; Pilar Mazzetti; Diana Rivas; Carlos Cosentino; Miguel Inca-Martinez; Juan M Cuba; Cyrus P Zabetian; James B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-01-15       Impact factor: 4.891

Review 3.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

4.  Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling.

Authors:  Kristi L Norris; Rui Hao; Liang-Fu Chen; Chun-Hsiang Lai; Meghan Kapur; Peter J Shaughnessy; Dennis Chou; Jin Yan; J Paul Taylor; Simone Engelender; Anna E West; Kah-Leong Lim; Tso-Pang Yao
Journal:  J Biol Chem       Date:  2015-04-10       Impact factor: 5.157

Review 5.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

Review 6.  Nrf2: a modulator of Parkinson's disease?

Authors:  Michael Todorovic; Stephen A Wood; George D Mellick
Journal:  J Neural Transm (Vienna)       Date:  2016-05-04       Impact factor: 3.575

7.  Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion.

Authors:  Sangwoo Ham; Seung Pil Yun; Hyojung Kim; Donghoon Kim; Bo Am Seo; Heejeong Kim; Jeong-Yong Shin; Mohamad Aasif Dar; Gum Hwa Lee; Yun Il Lee; Doyeun Kim; Sunghoon Kim; Hee-Seok Kweon; Joo-Ho Shin; Han Seok Ko; Yunjong Lee
Journal:  Sci Transl Med       Date:  2020-11-11       Impact factor: 17.956

Review 8.  Recent advances in Parkinson’s disease genetics.

Authors:  Steven Lubbe; Huw R Morris
Journal:  J Neurol       Date:  2014-02       Impact factor: 4.849

9.  Parkin disease: a clinicopathologic entity?

Authors:  Karen M Doherty; Laura Silveira-Moriyama; Laura Parkkinen; Daniel G Healy; Michael Farrell; Niccolo E Mencacci; Zeshan Ahmed; Francesca M Brett; John Hardy; Niall Quinn; Timothy J Counihan; Timothy Lynch; Zoe V Fox; Tamas Revesz; Andrew J Lees; Janice L Holton
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

10.  α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease.

Authors:  Risa Isonaka; David S Goldstein; William Zhu; Esther Yoon; Debra Ehrlich; Alice B Schindler; Angela D Kokkinis; Marya S Sabir; Sonja W Scholz; Sara Bandres-Ciga; Cornelis Blauwendraat; Pedro Gonzalez-Alegre; Grisel Lopez; Ellen Sidransky; Derek P Narendra
Journal:  Mov Disord       Date:  2021-06-02       Impact factor: 9.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.